Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Summary: Retatrutide is injected once weekly as a subcutaneous injection, based on Phase 2 clinical trial protocols, though it is not yet approved for use in the UK or elsewhere
found that GLP-1 RAs are associated with an increased risk of gallbladder and biliary diseases (including cholelithiasis and cholecystitis), particularly at higher doses, longer treatment durations, and when used for weight loss [129]
10.1053/j.semdp.2018.10.003 25 JiaoF.GongZ
DOI: 10.1038/s41586-026-10268-2.
US$ 24.04
US$ 28.37
US$ 21.98
US$ 23.29
_edited.jpg)
US$ 28.56
US$ 28.17
